Emerald Advisers’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Emerald Advisers’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-176,514	Closed	-$2.3M	–	322
2016 Q3	$2.3M	Hold	176,514	–	–	0.1%	194
2016 Q2	$1.21M	Buy	176,514 +9,329	+6%	+$78.1K	0.06%	228
2016 Q1	$1.58M	Sell	167,185 -69,885	-29%	-$564K	0.08%	215
2015 Q4	$2.39M	Buy	237,070 +130,869	+123%	+$1.73M	0.11%	191
2015 Q3	$1.52M	Buy	+106,201	New	+$2.61M	0.08%	230

Other funds holding ZYNE

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return